IRIS
CIABATTINI, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.318
EU - Europa 3.279
AS - Asia 608
AF - Africa 11
SA - Sud America 7
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.228
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.295
IT - Italia 699
IE - Irlanda 624
GB - Regno Unito 622
CN - Cina 321
SE - Svezia 305
RU - Federazione Russa 254
UA - Ucraina 207
FI - Finlandia 159
DE - Germania 152
SG - Singapore 147
FR - Francia 145
VN - Vietnam 70
IN - India 29
ES - Italia 22
CA - Canada 21
BE - Belgio 20
CZ - Repubblica Ceca 13
PL - Polonia 13
IR - Iran 11
NL - Olanda 11
CI - Costa d'Avorio 9
CH - Svizzera 6
GR - Grecia 6
LT - Lituania 5
IL - Israele 4
IQ - Iraq 4
TR - Turchia 4
BO - Bolivia 3
JP - Giappone 3
TH - Thailandia 3
AT - Austria 2
AU - Australia 2
BR - Brasile 2
EU - Europa 2
HK - Hong Kong 2
MX - Messico 2
MY - Malesia 2
NO - Norvegia 2
PK - Pakistan 2
PT - Portogallo 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 7.228
Salva come PNG Salva come JPEG
Città #
Dublin 622
Southend 540
Fairfield 477
Chandler 332
Ashburn 290
Santa Clara 266
Siena 255
Woodbridge 216
Jacksonville 172
Ann Arbor 160
Seattle 157
Cambridge 153
Houston 141
Wilmington 138
Singapore 114
Princeton 95
Beijing 85
Helsinki 74
Dong Ket 68
New York 65
Nanjing 58
Lappeenranta 53
Florence 50
San Mateo 31
Munich 30
Shanghai 30
Rome 29
San Diego 24
Boardman 22
Menlo Park 22
Shenyang 21
Brussels 20
Moscow 19
Milan 17
Lancaster 16
Málaga 16
London 15
Nanchang 15
Dearborn 14
Washington 13
Fremont 12
Hebei 12
Los Angeles 12
Redwood City 11
Kunming 10
Piscataway 10
Abidjan 9
Brno 9
Poggibonsi 9
San Francisco 9
Tianjin 9
Toronto 9
Jiaxing 8
Changsha 7
Frankfurt am Main 7
Jinan 7
Montreal 7
Norwalk 7
Bacoli 6
Phoenix 6
Agliana 5
Baronissi 5
Chicago 5
Düsseldorf 5
Guangzhou 5
Gurugram 5
Lastra a Signa 5
Naples 5
Redmond 5
Saint Louis 5
Venezia 5
Baghdad 4
Barolo 4
Columbus 4
Figline Valdarno 4
Kilburn 4
Lanciano 4
Napoli 4
Ottawa 4
Padova 4
Roccagorga 4
Slough 4
Taizhou 4
Triggiano 4
Zanjan 4
Zhengzhou 4
Atlanta 3
Bangalore 3
Chelyabinsk 3
Clifton 3
Gdynia 3
Hangzhou 3
Hounslow 3
Hyderabad 3
Izmir 3
Messina 3
Monteriggioni 3
Mumbai 3
Nuremberg 3
Prineville 3
Totale 5.268
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 238
Vaginal immunization to elicit primary T-cell activation and dissemination 237
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 229
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 204
Modulation of Primary Immune Response by Different Vaccine Adjuvants 193
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 185
Role of the microbiota in the modulation of vaccine immune responses 178
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 174
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 172
Ebola vaccine R&D: Filling the knowledge gaps 170
Vaccination in the elderly: The challenge of immune changes with aging 162
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 161
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 161
Bacillus spores for vaccine delivery 159
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 145
Adoptive transfer of transgenic T cells to study mucosal adjuvants 144
High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 143
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 140
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 139
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 136
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 135
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 135
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 134
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 129
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 127
Oral priming of mice by recombinant spores of Bacillus subtilis 121
Surface display of recombinant proteins on Bacillus subtilis spores 121
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 121
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 104
null 102
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 98
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 97
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 96
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 96
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 94
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 93
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 91
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 90
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 89
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 89
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 89
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 87
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 86
Primary T-cell response to mucosal vaccination 86
Expression of immunomodulating molecules on the surface of the vaccine vector Streptococcus gordonii 85
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 83
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 82
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 82
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 76
Primary activation of CD4+ and CD8+ T cells following mucosal vaccination with recombinant bacteria 74
Oral priming of mice using recombinant spores of Bacillus subtilis 73
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 70
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 64
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 63
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 60
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study 59
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 50
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 48
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 45
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein 45
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 45
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 39
Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers 39
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 38
Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2 37
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 36
Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients 31
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 20
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP 18
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach 17
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 15
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 14
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 7
Totale 7.395
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020557 0 0 0 0 0 0 105 137 89 120 40 66
2020/20211.066 46 88 33 72 72 98 38 130 90 188 96 115
2021/2022827 64 126 42 59 29 13 44 28 44 79 114 185
2022/20231.210 76 141 171 135 102 218 40 104 87 31 81 24
2023/20241.192 33 34 99 79 54 305 365 43 24 64 24 68
2024/20251.060 80 96 269 137 310 165 3 0 0 0 0 0
Totale 7.395